Pajjiż: Kanada
Lingwa: Franċiż
Sors: Health Canada
Tulathromycine
ZOETIS CANADA INC
100MG
Solution
Tulathromycine 100MG
Intramusculaire
20/50/100/250/500ML
Prescription
Bétails; Porcs; Mouton
Numéro de groupe d'ingrédients actifs (GIA) :0151667001
APPROUVÉ
2018-09-04
DIN 02285452 _TULATHROMYCIN STERILE INJECTABLE SOLUTION_ VETERINARY USE ONLY antibiotic DESCRIPTION: DRAXXIN® Injectable Solution is a ready-to- use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN Injectable Solution contains 100 mg of tulathromycin as the free base in a propylene glycol vehicle. DRAXXIN Injectable Solution consists of an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio. Structures of the isomers are shown below: FIGURE 1. The chemical names of the isomers are (2R,3S,4R,5R,8R,10R, 11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-O-methyl- 4 - C - [ ( p r o p y l a m i n o ) m e t h y l ] - α - L- r i b o - h e x o p y r a n o s y l ] oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl- 1 1 - [ [ 3 , 4 , 6 - t r i d e o x y - 3 - ( d i m e t h y l a m i n o ) - β - D - x y l o - hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one and (2R,3R,6R,8R,9R,10S,11S,12R)-11-[[2,6-dideoxy-3-C-methyl-3- O-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyranosyl] oxy]-2-[(1S,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy- 3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)- β-D-xylohexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one, respectively. INDICATIONS: BEEF AND NON-LACTATING DAIRY CATTLE: BOVINE RESPIRATORY DISEASE (BRD): DRAXXIN Injectable Solution is indicated for the treatment of BRD associated with _Mannheimia _ _haemolytica, _ _Pasteurella _ _multocida, _ _Histophilus _ _somni (Haemophilus somnus)_ and _Mycoplasma bovis_ and for the reduction of morbidity associated with BRD in feedlot calves caused by _Mannheimia _ _haemolytica, _ _Pasteurella _ _multocida, _ _Histophilus somni _and_ Mycoplasma bovis_, during the first 14 days in the feedlot when administered at the time of arrival. INFECTIOUS BOVINE KERATOCONJUNCTIVITIS (IBK): DRAXXIN Injectable Solution is indicated for the treatment of IBK associated with _Moraxella bovis_. FOOT ROT: DRAXXIN Injectable Solution Aqra d-dokument sħiħ